What is the scope of the guideline?
The scope of the guideline is outlined in S1.4-1 to S1.4-4, which refer to Baigent et al. (2010), Chou et al. (2016), Taylor et al. (2013) and Stone et al. (2014), respectively. These references provide evidence for the efficacy and safety of more intensive lowering of LDL cholesterol, statin use for the prevention of cardiovascular disease, and the 2013 ACC/AHA guidelines on the treatment of blood cholesterol. 